Richard J. Daly - Jan 1, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
President and CEO, Director
Signature
/s/ Richard J. Daly
Stock symbol
CPRX
Transactions as of
Jan 1, 2024
Transactions value $
$0
Form type
4
Date filed
1/3/2024, 05:18 PM
Previous filing
Dec 29, 2023
Next filing
Feb 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +1.37M +685.51% $0.00 1.56M Jan 1, 2024 Common Stock 1.37M $13.30 Direct F1, F2
transaction CPRX Restricted Stock Units Award $0 +211K +13.46% $0.00 1.78M Jan 1, 2024 Common Stock 211K Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price of derivative security is based upon the date on which the Reporting Person's executed their offer letter (dated October 18, 2023) with the Registrant, in accordance with the Registrant's 2018 Stock Incentive Plan. Mr. Daly became the Registrant's President and Chief Executive Officer on January 1, 2024 and remains a member of the Registrant's Board of Directors.
F2 Derivative securities vest in five equal annual tranches beginning on January 1, 2025.
F3 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F4 Shares of common stock will be delivered to the Reporting Person upon vesting.